ALERT-FDA-DRUG SHORTAGE-DIAZEPAM & VOLUNTARY RECALL ORTHO-NOVUM

From the Food & Drug Administration

Diazepam Injection
Status: Currently in Shortage

Date first posted: 09/22/2017
Therapeutic Categories: Neurology

Hospira Inc.
10 mg/2 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1273-32)
Next Delivery: November 2018; Estimated Recovery: March 2019

For details see FDA,

https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?utm_campaign=11-02-2018%20Drug%20Shortages&utm_medium=email&utm_source=Eloqua&AI=Diazepam+Injection%2C+USP&st=c&tab=tabs-4&panels=1&elqTrackId=7d183962d2e243ad941df4f8ad40dd17&elq=1bb6c85319804958920136a04ffef82b&elqaid=5756&elqat=1&elqCampaignId=4639

_________________________________________________________________________________________

ORTHO-NOVUM 1/35 & ORTHO-NOVUM 7/7/7-Voluntary Recall

Janssen Issues Voluntary Nationwide Recall for one lot of ORTHO-NOVUM 1/35 and two lots of ORTHO-NOVUM 7/7/7

Due to Incorrect Veridate Dispenser Instructions

TITUSVILLE, NJ – Janssen Pharmaceuticals, Inc. has initiated a voluntary recall of one lot of ORTHO-NOVUM® 1/35 (norethindrone/ethinyl estradiol) Tablets and two lots of ORTHO-NOVUM® 7/7/7 (norethindrone/ethinyl estradiol) Tablets to the pharmacy level. The patient information provided inside affected packages of ORTHO-NOVUM® does not include the appropriate instructions for the Veridate® dispenser.

The potential risk of taking ORTHO-NOVUM without the appropriate instructions for correct use of the Veridate® dispenser pack is that the consumer could take the pills in the incorrect order (still receiving an effective dose) or could take an inactive “reminder” pill instead of an “active” pill which could lead to breakthrough bleeding or an unintended pregnancy.

For full details see FDA,

https://www.fda.gov/Safety/Recalls/ucm625012.htm?utm_campaign=FDA%20MedWatch%20Recall%20Notice%20-%20%20ORTHO-NOVUM%201%2F35&utm_medium=email&utm_source=Eloqua